Showing results (411-420 of 1,169) with videos related to
Sort By:
Pageof 117
Neurology|February 13, 2002
MRI metrics as surrogate markers for clinical relapse rate in relapsing-remitting MS patientsMaria Pia Sormani, Paolo Bruzzi, Giancarlo Comi, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 20, 2015
Regional hippocampal involvement and cognitive impairment in pediatric multiple sclerosisMaria A Rocca, Maria E Morelli, Maria P Amato, et al.Human Brain Mapping|July 22, 2014
Functional correlates of cognitive dysfunction in multiple sclerosis: A multicenter fMRI StudyMaria A Rocca, Paola Valsasina, Hanneke E Hulst, et al.International Journal of Cardiology. Heart & Vasculature|September 9, 2020
Extent and characteristics of carotid plaques and brain parenchymal loss in asymptomatic patients with no indication for revascularizationEnrico Ammirati, Francesco Moroni, Marco Magnoni, et al.Neurology|March 21, 2014
Posterior brain damage and cognitive impairment in pediatric multiple sclerosisMaria A Rocca, Martina Absinta, Maria Pia Amato, et al.Journal of Neurology|November 9, 2022
Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network InitiativeAlessandro Pasquale De Rosa, Fabrizio Esposito, Paola Valsasina, et al.Frontiers in Artificial Intelligence|April 27, 2026
Machine learning for multiple sclerosis classification and disability prediction using clinical and MRI dataPaola Valsasina, Loredana Storelli, Nicolò Tedone, et al.Journal of Neurology|April 9, 2025
Clinical and MRI features contributing to the clinico-radiological dissociation in a large cohort of people with multiple sclerosisAbhineet Ojha, Silvia Tommasin, Claudia Piervincenzi, et al.Neuroimage. Clinical|March 4, 2022
MAGNIMS recommendations for harmonization of MRI data in MS multicenter studiesNicola De Stefano, Marco Battaglini, Deborah Pareto, et al.Journal of Neurology, Neurosurgery, and Psychiatry|February 25, 2012
A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosisMerja Soilu-Hänninen, Julia Aivo, Britt-Marie Lindström, et al.Pageof 117